IFNG and pancreatic neoplasm: As shown in Fig. 7B, IFN-γ expression was not increased significantly in αPD-1-treated group compared to PBS-treated group, suggesting that ICI alone could not sufficiently induce antitumor immune response in a poorly immunogenic pancreatic cancer.